» Authors » Antonio Rezusta

Antonio Rezusta

Explore the profile of Antonio Rezusta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 89
Citations 1027
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Latorre-Millan M, Tristancho-Baro A, Burillo N, Ariza M, Milagro A, Abad P, et al.
Viruses . 2025 Feb; 17(2). PMID: 40007002
High-risk human papillomavirus (HR-HPV) and other sexually transmitted infections (STIs-O) are promoters to the development of cervical cancer (CC), especially when they co-exist. This study aims to determine the prevalence...
2.
Lafarga-Molina L, Rubio E, Seral C, Rezusta A, Lizan P, Malo Aznar C, et al.
Microorganisms . 2025 Feb; 13(2). PMID: 40005664
Giardiasis and cryptosporidiosis, caused by and spp., are parasitic infections transmitted through faecal-oral routes or contaminated water. Although less common in Spain compared to developing countries, they pose a public...
3.
Martinez-Martinez A, Tristancho-Baro A, Garcia-Rodriguez B, Clavel-Millan M, Palacian M, Milagro A, et al.
Viruses . 2025 Jan; 17(1). PMID: 39861827
This study explores the relationship between specific SARS-CoV-2 mutations and obesity, focusing on how these mutations may influence COVID-19 severity and outcomes in high-BMI individuals. We analyzed 205 viral mutations...
4.
Tristancho-Baro A, Franco-Fobe L, Ariza M, Milagro A, Lopez-Calleja A, Fortuno B, et al.
Antibiotics (Basel) . 2025 Jan; 14(1). PMID: 39858329
: Infections caused by multidrug-resistant (MDR)bacteria pose a significant public health threat by worsening patient outcomes, contributing to hospital outbreaks, and increasing health and economic burdens. Advanced genomic tools enhance...
5.
Latorre-Millan M, Rodriguez Del Aguila M, Clusa L, Mazagatos C, Larrauri A, Fernandez M, et al.
Viruses . 2024 Nov; 16(11). PMID: 39599820
In the frame of the I-MOVE-COVID-19 project, a cohort of 2050 patients admitted in two Spanish reference hospitals between March 2020 and December 2021 was selected and a range of...
6.
Peris M, Alonso H, Escolar C, Tristancho-Baro A, Abad M, Rezusta A, et al.
Antibiotics (Basel) . 2024 Nov; 13(11). PMID: 39596706
and can cause similar clinical syndromes and may coexist in infections. In emergency medicine, empirical treatment targeting both pathogens is often employed, potentially contributing to antibiotic resistance. Gonococcal resistance has...
7.
Eguizabal P, Lopez-Calleja A, Arias A, Antonanzas-Torres I, Campana-Burguet A, Gonzalez-Azcona C, et al.
Microb Pathog . 2024 Oct; 197:107016. PMID: 39413853
Purpose: Staphylococcus aureus is one of the most prevalent pathogens in cystic fibrosis (CF), being of special relevance those methicillin-resistant (MRSA). The livestock-associated (LA)-MRSA lineage CC398 is an emerging problem,...
8.
Tristancho-Baro A, Vineta-Valdelvira V, Rezusta A, Garcia-Lechuz J
BMC Infect Dis . 2024 Jul; 24(1):753. PMID: 39080594
Background: Mediterraneibacter gnavus is a Gram positive, non-sporulated, obligate anaerobe diplococci. It was first described in 1974 by Moore et al. (under the name Ruminococcus gnavus) from faeces and contents...
9.
Spruijtenburg B, Rezusta A, Houbraken J, Hagen F, de Groot T, Meis J, et al.
Mycopathologia . 2024 Jul; 189(4):61. PMID: 38958798
The genus Aspergillus consists of a vast number of medically and environmentally relevant species. Aspergillus species classified in series Versicolores are ubiquitous in the environment and include the opportunistic pathogen...
10.
Martinez-Martinez A, Lamban-Per B, Lezaun M, Rezusta A, Arbones-Mainar J
Nutrients . 2024 Jun; 16(12). PMID: 38931178
Research on the microbiome has progressed from identifying specific microbial communities to exploring how these organisms produce and modify metabolites that impact a wide range of health conditions, including gastrointestinal,...